Identification of TP53 mutation-associated prognostic genes and investigation of the immune cell infiltration in patients with hepatocellular carcinoma

被引:0
|
作者
Yang, Qijun [1 ]
Gao, Lianke [3 ]
Xu, Yuhan [2 ]
Cao, Gaoquan [4 ]
He, Yingcheng
Zhang, Wenyige [2 ]
Zhang, Xue [2 ]
Wu, Chengfeng [5 ]
Liao, Kaili [1 ]
Wang, Xiaozhong [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Clin Lab, Nanchang 330006, Jiangxi, Peoples R China
[2] Nanchang Univ, Queen Mary Coll, Nanchang 330031, Jiangxi, Peoples R China
[3] Nanchang Univ, Adv Mfg Coll, Nanchang 330031, Jiangxi, Peoples R China
[4] Nanchang Univ, Clin Sch 4, South Rd Bayi Sq, Nanchang 330031, Jiangxi, Peoples R China
[5] Nanchang Univ, Affiliated Hosp 2, Dept Vasc Surg, Nanchang 330006, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.gendis.2023.03.020
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
[No abstract available]
引用
收藏
页码:520 / 523
页数:4
相关论文
共 50 条
  • [41] Elucidating the immune landscape and potential prognostic model in acute myeloid leukemia with TP53 mutation
    Zhu, Gelan
    Cai, Jiayi
    Fu, Wanbin
    Sun, Yue
    Wang, Ting
    Zhong, Hua
    HEMATOLOGY, 2024, 29 (01)
  • [42] A novel immune-associated prognostic signature based on the immune cell infiltration analysis for hepatocellular carcinoma
    Lin, Xinrong
    Tian, Chuan
    Pan, Fan
    Wang, Rui
    ONCOLOGIE, 2024, 26 (01) : 91 - 103
  • [43] A special prognostic indicator: tumor mutation burden combined with immune infiltrates in lung adenocarcinoma with TP53 mutation
    Fu, Jing
    Li, Yaonan
    Li, Cuidan
    Tong, Yuyang
    Li, Mengyuan
    Cang, Shundong
    TRANSLATIONAL CANCER RESEARCH, 2021, 10 (09) : 3963 - +
  • [44] TP53 K351N mutation-associated platinum resistance after neoadjuvant chemotherapy in patients with advanced ovarian cancer
    Zhang, Guo-nan
    Liu, Hong
    Huang, Jian-ming
    Wang, Ling
    Zhao, Jing-sha
    Li, Chao
    Mi, Kun
    Zhu, Yi
    Cheng, Jia
    Zha, Xiao
    GYNECOLOGIC ONCOLOGY, 2014, 132 (03) : 752 - 757
  • [45] TP53 and RET may serve as biomarkers of prognoStic evaluation and targeted therapy in hepatocellular carcinoma
    Ye, Song
    Zhao, Xin-Yi
    Hu, Xiao-Ge
    Li, Tang
    Xu, Qiu-Ran
    Yang, Huan-Ming
    Huang, Dong-Sheng
    Yang, Liu
    ONCOLOGY REPORTS, 2017, 37 (04) : 2215 - 2226
  • [46] Identification of GINS2 prognostic potential and involvement in immune cell infiltration in hepatocellular carcinoma
    Li, Zuyin
    Song, Guohe
    Guo, Dezhen
    Zhou, Zhijie
    Qiu, Chen
    Xiao, Chao
    Wang, Xiaoliang
    Wang, Yupeng
    JOURNAL OF CANCER, 2022, 13 (02): : 610 - 622
  • [47] Identification of circadian clock genes as regulators of immune infiltration in Hepatocellular Carcinoma
    Zhang, Zhen
    Liang, Zicheng
    Gao, Wenhui
    Yu, Shuxian
    Hou, Zongwei
    Li, Kexin
    Zeng, Puhua
    JOURNAL OF CANCER, 2022, 13 (11): : 3199 - 3208
  • [48] Identification of disulfidptosis-related genes with immune infiltration in hepatocellular carcinoma
    Li, Xiao-min
    Liu, Shan-peng
    Li, Yu
    Cai, Xiao-ming
    Zhang, Shao-bo
    Xie, Ze-feng
    HELIYON, 2023, 9 (08)
  • [49] Novel TP53 coding region mutation in the patients of oral squamous cell carcinoma (OSCC) of Pakistan
    Azhar, Abid
    Saleem, Saima
    Hameed, Abdul
    Khan, Mansoor Ahmed
    Abbasi, Zubair
    Qureshi, Navid Rashid
    ORAL ONCOLOGY, 2013, 49 : S42 - S42
  • [50] Identification of Crucial Cancer Stem Cell Genes Linked to Immune Cell Infiltration and Survival in Hepatocellular Carcinoma
    Huang, Lien-Hung
    Wu, Shao-Chun
    Liu, Yueh-Wei
    Liu, Hang-Tsung
    Chien, Peng-Chen
    Lin, Hui-Ping
    Wu, Chia-Jung
    Hsieh, Ting-Min
    Hsieh, Ching-Hua
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (22)